A pilot study of stiripentol, a new anticonvulsant drug, in complex partial seizures uncontrolled by carbamazepine.
Rascol
O
O
Service de Pharmacologie Médicale et Clinique INSERM U 317, Centre Hospitalier Universitaire, Faculté de Médecine, Toulouse, France.
Squalli
A
A
Montastruc
J L
JL
Garat
A
A
Houin
G
G
Lachau
S
S
Tor
J
J
Blehaut
H
H
Rascol
A
A
D000328:Adult; D000368:Aged; D000927:Anticonvulsants / Q000097:blood / Q000494:pharmacology*; D002220:Carbamazepine / Q000097:blood / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004148:Dioxolanes / Q000097:blood / Q000494:pharmacology*; D004149:Dioxoles / Q000494:pharmacology*; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004833:Epilepsy, Temporal Lobe / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010634:Phenobarbital / Q000097:blood / Q000627:therapeutic use; D010865:Pilot Projects; D014635:Valproic Acid / Q000097:blood / Q000627:therapeutic use
D000927:Anticonvulsants; D004148:Dioxolanes; D004149:Dioxoles; D002220:Carbamazepine; D014635:Valproic Acid; C021092:stiripentol; D010634:Phenobarbital